China Biopharmaceutical: Pre-clinical studies of the weight loss drug TQF6422 showed better fat loss effects and supported longer dosing intervals.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.